LSK Global Pharma Services Co. Ltd.   Report issue

For profit Phase 1
Founded: Seoul Korea, Republic of (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2009
NCT01867957
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

LSK Global Pharma Services Co. Ltd.

Active Ingredients

Drugs in Phase 1 Trials (1)

gc1109 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anthrax (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1